Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Tapestry, Inc. in the acquisition of Capri Holdings advised by Wachtell, Lipton, Rosen & Katz. Tapestry, Inc. (NYSE: TPR), a house of...
You must be a Standard 1 Year member to access this content.
Latham Secures Dismissal With Prejudice of Stockholder Class Action Complaint for Switch, Inc. Challenging US$11 Billion Take-Private Transaction. A Southern-California Latham securities litigation team earned a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises Guardant Health in Pricing of Upsized Public Offering of Common Stock. Guardant Health, Inc., a leading precision oncology company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented UNITY Biotechnology in the transaction. UNITY Biotechnology, Inc. (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...
You must be a Standard 1 Year member to access this content.
Cooley represented Mirum Pharmaceuticals, while Latham & Watkins represented the underwriters in the offering. Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised the Special Committee of the Board of Directors of Switch, and Simpson Thacher & Bartlett advised DigitalBridge and IFM on the deal....
You must be a Standard 1 Year member to access this content.
Orrick, Herrington & Sutcliffe advised Twist Bioscience, while Latham & Watkins represented the underwriters in the offering. Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers...
You must be a Standard 1 Year member to access this content.
